Fortress Biotech, Inc. (FBIO)
Last updated: 2026-10-21 12:52:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
Fortress Biotech, Inc. (FBIO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.94, with a market capitalization of $62.37M and a P/E ratio of 0.63. Over the past 52 weeks, its price has ranged from $1.83 to $4.53. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$62.37M | |
$1.94 | |
$91.50 | |
$1.24 | |
$1.94 | |
1.12K | |
438.48K | |
0.63 | |
$4.53 | |
$1.83 | |
0.51% | |
-- |
Fortress Biotech, Inc. (FBIO) Pre-Market Stock Price
Fortress Biotech, Inc. (FBIO) is trading at $1.94 in pre-market trading as of 2026-10-21 12:48:00, down 0.26% ($0.00) from the previous close of $1.94
Pre-market trading shows how investors are pricing FBIO before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.
Fortress Biotech, Inc. (FBIO) 7-Day Stock Price Change
Over the past seven days, Fortress Biotech, Inc. (FBIO) moved from $2.11 to $1.94, representing a decline of 8.29% ($0.17).
The stock traded between $1.83 and $2.13 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 280.46 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
FBIO 52-Week Price Position
Position in Range: 3.9%
FBIO is currently trading at $1.94, placing it 3.9% of the way from its 52-week low of $1.83 to its 52-week high of $4.53. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Fortress Biotech, Inc. (FBIO)?
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.
Fortress Biotech, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 78 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Fortress Biotech, Inc. (FBIO) Stock on MEXC
Eligible investors can buy real shares of Fortress Biotech, Inc. (FBIO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Fortress Biotech, Inc. (FBIO) stock price today?
2.Is FBIO stock going up or down today?
3.What is FBIO pre-market price?
4.What is FBIO after-hours price?
5.Is FBIO stock trading now?
6.Where does FBIO sit relative to its 52-week high and low?
7.What sector is Fortress Biotech, Inc. in?
8.What is Fortress Biotech, Inc.'s market capitalization and where is it listed?
9.How is FBIO valued in terms of P/E ratio and EPS?
10.Does Fortress Biotech, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
FBIO Stock Calculator
Estimate the value between FBIO shares and USD.
FBIO Shares to USD
1.00 FBIO shares = 1.935 USD
Calculations are estimates based on the latest available price and are for reference only.


